Ascentage Pharma Group International (AAPG) Stock Insights
AAPG$15.03+0.18 +1.21%
$1.40B
Market Cap
-6.29
P/E
4.50
Forward P/E
41
Score
Ascentage Pharma Group International (AAPG) Stock Insights
AAPG price $15.03 +0.18 +1.21%
- Ticker
- AAPG
- Price
- $15.03
- Change
- +0.18 +1.21%
- Market cap ?
- $1.40B
- P/E ?
- -6.29
- Forward P/E ?
- 4.50
- Dividend yield ?
- 0.00%
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 41
- Value
- 56
- Quality
- 15
- Growth
- 52
Stocklytics score rationale: value 56, quality 15, growth 52.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 7667000 | 6328000 | 6807000 | 14513000 | 12450000 | 27910000 | 209711000 | 221984000 | 980650000 | 558478193 |
Based in Suzhou, China, Ascentage Pharma Group International is a biotechnology firm primarily focused on clinical-stage development. The company is dedicated to discovering and advancing therapeutic solutions for a range of medical conditions, including various cancers, chronic hepatitis B virus (HBV) infections, and age-related ailments. A cornerstone of its product pipeline is HQP1351, a BCR-ABL inhibitor…
Fair value
AAPG fair value $81.24. Price $15.03. Price is 81% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 55.57M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 92.96M. Net debt -490.68M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2027-03-31 | — | -0.30 | — | 49.77M |
| 2026-08-18 | -1.30 | -0.22 | 44.85M | 53.63M |
| 2026-03-24 | -0.65 | -0.83 | 49.49M | 44.40M |
| 2025-08-20 | -0.96 | — | 32.55M | — |
| 2025-03-27 | -1.00 | 0.02 | 21.49M | — |
| 2024-08-22 | 0.31 | — | 115.41M | — |
| 2023-12-31 | -1.02 | — | 11.19M | — |
| 2023-08-21 | -0.81 | — | 19.57M | — |
| 2022-12-31 | -3.91 | — | 15.31M | — |
| 2022-08-26 | -0.89 | — | 13.84M | — |
| 2021-12-31 | -3.86 | — | 339.77K | — |
| 2021-08-24 | -0.94 | — | 2.00M | — |
| 2020-12-31 | -3.85 | — | 953.61K | — |
| 2020-08-18 | -0.89 | — | 378.20K | — |
| 2019-12-31 | -8.13 | — | 1.05M | — |
| 2019-06-30 | -8.15 | — | 1.06M | — |
| 2018-12-31 | -4.05 | — | 1.02M | — |
| 2018-06-30 | -0.02 | — | 21.33K | — |
| 2017-12-31 | -1.35 | — | 918.81K | — |
| 2017-06-30 | -0.04 | — | 40.50K | — |
| 2016-12-31 | -0.60 | — | 551.55K | — |
| 2016-06-30 | -0.63 | — | 576.65K | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-25 | Miyara Faical | Other | 0 | — | — |
| 2026-05-21 | Zhai Yifan | Buy | 95.58K | — | — |
| 2026-05-21 | Zhai Yifan | Buy | 92.75K | — | — |
| 2026-05-21 | Zhai Yifan | Sell | 95.58K | — | — |
| 2026-05-21 | Yang Dajun | Buy | 95.58K | — | — |
| 2026-05-21 | Yang Dajun | Buy | 92.75K | — | — |
| 2026-05-21 | Yang Dajun | Sell | 92.75K | — | — |
| 2026-05-20 | Zhai Yifan | Buy | 298.19K | — | — |
| 2026-05-20 | Zhai Yifan | Buy | 298.19K | $6.58 | 1.96M |
| 2026-05-20 | Zhai Yifan | Buy | 215.00K | — | — |
| 2026-05-20 | Zhai Yifan | Buy | 214.99K | $6.58 | 1.41M |
| 2026-05-20 | Zhai Yifan | Buy | 103.36K | — | — |
| 2026-05-20 | Zhai Yifan | Buy | 103.36K | $8.12 | 839.32K |
| 2026-05-20 | Zhai Yifan | Buy | 95.58K | — | — |
| 2026-05-20 | Zhai Yifan | Buy | 92.75K | — | — |
| 2026-05-20 | Yang Dajun | Buy | 298.19K | $6.58 | 1.96M |
| 2026-05-20 | Yang Dajun | Buy | 215.00K | — | — |
| 2026-05-20 | Yang Dajun | Buy | 214.99K | $6.58 | 1.41M |
| 2026-05-20 | Yang Dajun | Buy | 103.36K | — | — |
| 2026-05-20 | Yang Dajun | Buy | 103.36K | $8.12 | 839.32K |
| 2026-05-20 | Yang Dajun | Buy | 95.58K | — | — |
| 2026-05-20 | Yang Dajun | Buy | 92.75K | — | — |
| 2026-05-20 | Yang Dajun | Buy | 298.19K | — | — |
| 2026-04-20 | Misra Veet | Buy | 18.58K | — | — |
| 2026-03-18 | Misra Veet | Other | 0 | — | — |
| 2026-03-18 | Cao Jin | Other | 0 | — | — |
| 2026-03-18 | Cao Jin | Other | 12.88K | — | — |
| 2026-03-18 | Zhai Yifan | Other | 0 | — | — |
| 2026-03-18 | Zhai Yifan | Other | 0 | — | — |
| 2026-03-18 | Zhai Yifan | Other | 0 | — | — |
| 2026-03-18 | Zhai Yifan | Other | 0 | — | — |
| 2026-03-18 | Zhai Yifan | Other | 103.36K | $8.14 | 841.38K |
| 2026-03-18 | Zhai Yifan | Other | 103.36K | — | — |
| 2026-03-18 | Wei Ren | Other | 0 | — | — |
| 2026-03-18 | Wei Ren | Other | 18.85K | $8.14 | 153.44K |
| 2026-03-18 | Wei Ren | Other | 28.85K | — | — |
| 2026-03-18 | Ye Changqing | Other | 0 | — | — |
| 2026-03-18 | Ye Changqing | Other | 28.85K | — | — |
| 2026-03-18 | Yu Debra | Other | 27.96K | — | — |
| 2026-03-18 | Lu Simon Dazhong | Other | 0 | — | — |
| 2026-03-18 | Lu Simon Dazhong | Other | 27.96K | — | — |
| 2026-03-18 | SIDRANSKY DAVID | Other | 0 | — | — |
| 2026-03-18 | SIDRANSKY DAVID | Other | 28.85K | — | — |
| 2026-03-18 | Wang Shaomeng | Other | 0 | — | — |
| 2026-03-18 | Wang Shaomeng | Other | 0 | — | — |
| 2026-03-18 | Wang Shaomeng | Other | 0 | — | — |
| 2026-03-18 | Wang Shaomeng | Other | 17.96K | $8.14 | 146.24K |
| 2026-03-18 | Wang Shaomeng | Other | 27.96K | — | — |
| 2026-03-18 | LIPPMAN MARC E | Other | 27.96K | — | — |
| 2026-03-18 | Knapp Thomas J | Other | 0 | — | — |
| 2026-03-18 | Knapp Thomas J | Other | 38.94K | $8.14 | 316.96K |
| 2026-03-18 | Knapp Thomas J | Other | 38.94K | — | — |
| 2026-03-18 | Bozilenko Marina | Other | 27.96K | — | — |
| 2026-03-18 | Ye Changqing | Other | 56.55K | $8.14 | 460.32K |
| 2026-03-18 | Ye Changqing | Other | 66.55K | — | — |
| 2026-03-18 | Bozilenko Marina | Other | 53.90K | $8.14 | 438.71K |
| 2026-03-18 | Bozilenko Marina | Other | 63.90K | — | — |
| 2026-03-18 | Yang Dajun | Other | 0 | — | — |
| 2026-03-18 | Yang Dajun | Other | 0 | — | — |
| 2026-03-18 | Yang Dajun | Other | 0 | — | — |
| 2026-03-18 | Yang Dajun | Other | 0 | — | — |
| 2026-03-18 | Yang Dajun | Other | 103.36K | $8.14 | 841.38K |
| 2026-03-18 | Yang Dajun | Other | 103.36K | — | — |
| 2026-03-18 | SIDRANSKY DAVID | Other | 56.55K | $8.14 | 460.32K |
| 2026-03-18 | SIDRANSKY DAVID | Other | 66.55K | — | — |
| 2026-03-18 | Lu Simon Dazhong | Other | 53.90K | $8.14 | 438.71K |
| 2026-03-18 | Lu Simon Dazhong | Other | 63.90K | — | — |
| 2026-03-18 | LIPPMAN MARC E | Other | 0 | — | — |
| 2026-03-18 | LIPPMAN MARC E | Other | 53.90K | $8.14 | 438.71K |
| 2026-03-18 | LIPPMAN MARC E | Other | 63.90K | — | — |
| 2026-03-18 | Yu Debra | Other | 53.90K | $8.14 | 438.71K |
| 2026-03-18 | Yu Debra | Other | 63.90K | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 7, holders +1 vs prior quarter. Ownership 0.02%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 13.84K | -2.21K | -13.80% | 243.05K |
| MORGAN STANLEY | 919 | 421 | +84.54% | 16.14K |
| WELLS FARGO & COMPANY/MN | 200 | 200 | New | 3.51K |
| EVERSOURCE WEALTH ADVISORS, LLC | 24 | 0 | 0.00% | 421 |
| UBS GROUP AG | 15 | -109 | -87.90% | 263 |
| BLACKROCK, INC. | 6 | 6 | New | 105 |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 1 | 1 | New | 18 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0 | -518 | -100.00% | 0 |
| XY CAPITAL LTD | 0 | -13.01K | -100.00% | 0 |
Insights · Dividends · Forecast · Financials · Learn